Skip to content

Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients

Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients: Validation Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02128477
Acronym
PRD-MI
Enrollment
754
Registered
2014-05-01
Start date
2010-10-31
Completion date
2016-12-31
Last updated
2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Myocardial infarction, Repolarization instability, Ventricular fibrillation

Brief summary

Increased periodic repolarization dynamics (PRD) indicate increased risk of death in cardiac patients. This study thoughts to prospectively validate the prognostic value of PRD in post-infarction patients.

Detailed description

Periodic repolarization dynamics (PRD) reflect periodic changes of repolarization instability located in the low-frequency spectral range. Level of PRD can be assessed using a high resolution surface ECG recorded in the 12-leads of Frank leads configuration during resting conditions. Increased levels of PRD have been associated with sympathetic overactivity and increased risk of mortality in survivors of acute myocardial infarction and patients undergoing a clinically indicated exercise test.

Interventions

None listed

Sponsors

Thebiosignals.com
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* previous myocardial infarction \>4 weeks * age \>18 years

Exclusion criteria

* life expectancy \< 1 year due to non-cardiac causes * unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Number of total deaths24 months

Secondary

MeasureTime frame
Number of cardiovascular deaths24 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026